Clintex's CTi (Clinical Trials Intelligence) is a decentralised enterprise solution that will bring down the cost of medicine, as well as increase the speed of access to new medicine to the people that need it, by reducing development costs for the global pharmaceutical industry.
It will achieve this by revolutionising how clinical trials are conducted through the innovative use of a combination of smart contracts both on their private consortium blockchain and on the Ethereum public blockchain. The platform is at its core a decentralised database of clinical data, but also will host 7 separate applications, the primary function of which will be the management and optimisation of the key pain points in the conducting of clinical trials.
All ratings published on ICObench serve informational purposes only. ICObench does not provide investment forecast, recommendations or any consulting for that matter. Thus, neither ICObench, nor the experts can be hold responsible for the visitors’ investment decisions. Read more
Solid team, solid platform and concept, I think the pharmaceutical industry needs a more open source approach not only from clinic to clinic but also to patients aswell. In my opinion clinics should be transparent with patients every step of the way and hope this will bridge the gap.
I like the uniqueness of the platform and using Blockchain to real world use other then just cryptocurrency, this is game-changing.
The whitepaper is very well done. I am impressed with the different versions of whitepapers and level of detail for each.
I also think the scope of 2 years or so as suggested in the roadmap to develop such a platform is bang on.
I think having a live working prototype demo link would be good though during ICO.
Other then that I think it's a great looking business model and wish you all the very best success with the ICO.
Experts are independently and voluntarily contributing to the community. If no expert has rated the ICO, only ICO analyzer's results are used. Always research before investing as these ratings should not be taken as an investing guide of any kind.
Ratings and ICO analyzer results are being updated (re-calculated) every few hours.